Cardiovascular Digital Solutions Market Analysis

Component (Devices, Software)

Devices segment is likely to account for around 58.7% cardiovascular digital solutions market share by 2037, owing to the increasing uptake of wearable technology, remote monitoring technologies, and the need for continuous, real-time health data. Continued advancements in technology and increased health consciousness are contributing to this growth. In August 2024, GE Healthcare announced the CE mark of its Vscan Air SL wireless handheld ultrasound solution for rapid cardiac assessment.

Application (Cardiac monitoring and diagnosis, CVD health informatics, Cardiac rehab programs)

By 2037, cardiac monitoring and diagnosis segment is set to capture over 57.1% cardiovascular digital solutions market share, owing to growing incidence rates of CVDs, increased use of remote patient monitoring, and constant improvements in wearable technology. The growth of this segment is brought about by new developments in wearable devices such as smartwatches and patch monitors, which enable the tracking of heart rates, ECG, and blood pressure. In March 2024, Wellysis partnered with Arthella Solutions to launch innovative remote monitoring services for cardiac health in the U.S.

Our in-depth analysis of the cardiovascular digital solutions market includes the following segments:

Component	Devices Software
Application	Cardiac Monitoring and Diagnosis CVD Health Informatics Cardiac Rehab Programs Others
Deployment Mode	Cloud-based On-Premises
End use	Hospitals & Clinics Homecare Others

Frequently Asked Questions (FAQ)

In 2024, the industry size of the market was USD 101.7 billion.

The market size of the cardiovascular digital solution industry is projected to cross USD 211.7 billion by the end of 2037 expanding at a CAGR of 6.3% during the forecast period i.e., between 2025-2037.

The major players in the market are AliveCor, Inc., Apple Inc., Baxter, Cardiac, Insight, Inc., Cardiotrack, EviCore Healthcare, Garmin, GE Healthcare, HeartFlow, and others.

In terms of application, cardiac monitoring and diagnosis is anticipated to garner the largest market share of 57.1% by 2037 and display substantial growth opportunities during 2025-2037.

The market in North America is projected to hold the largest revenue share of 33.2% by the end of 2037 and provide more business opportunities in the future.

Cardiovascular Digital Solutions Market Analysis